Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Int J Colorectal Dis. 2013 Mar;28(3):415-24. doi: 10.1007/s00384-012-1570-z. Epub 2012 Sep 9.
Preclinical and clinical studies have indicated that vascular endothelial growth factor (VEGF) is the predominant angiogenic factor. Recently, there was a consistent trend of poorer survival rates in colorectal cancer (CRC) patients of earlier relapse. The purpose of this study was to investigate novel predictors of early relapse in stage I-III CRC and further to determine their correlation with disease outcomes.
We retrospectively analyzed clinicopathological features and VEGF expression by immunohistochemical staining in 100 stage I-III CRC patients undergoing curative resection to identify predictors of postoperative early relapse.
Among 100 patients, 40 patients were classified into early relapse group, and 60 patients were categorized into non-early relapse group. A multivariate logistic regression analysis showed that vascular invasion (P = 0.048), perineural invasion (P = 0.042), VEGF overexpression (P = 0.023), and high postoperative carcinoembryonic antigen (CEA) levels (P = 0.004) were independent predictors of early relapse. Additionally, we found that with more predictors such as the combined incidence of vascular invasion, perineural invasion, VEGF overexpression, and postoperative CEA levels are involved, the incidence of early postoperative relapse increases. Moreover, VEGF overexpression predicted not only early postoperative relapse but also disease-free survival (P < 0.001) and overall survival (P = 0.002).
This study suggests that VEGF overexpression is an important predictor of early postoperative relapse in patients with stage I-III CRC and may help identify patients who would benefit from intensive follow-up and therapeutic programs.
临床前和临床研究表明血管内皮生长因子(VEGF)是主要的血管生成因子。最近,结直肠癌(CRC)患者早期复发的生存率持续下降。本研究旨在探讨 I-III 期 CRC 早期复发的新预测因子,并进一步确定其与疾病结局的相关性。
我们回顾性分析了 100 例接受根治性切除术的 I-III 期 CRC 患者的临床病理特征和免疫组织化学染色 VEGF 表达,以确定术后早期复发的预测因子。
在 100 例患者中,40 例患者被分为早期复发组,60 例患者被分为非早期复发组。多变量逻辑回归分析显示血管侵犯(P=0.048)、神经周围侵犯(P=0.042)、VEGF 过表达(P=0.023)和术后癌胚抗原(CEA)水平升高(P=0.004)是早期复发的独立预测因子。此外,我们发现随着更多的预测因子(如血管侵犯、神经周围侵犯、VEGF 过表达和术后 CEA 水平的联合发生率)的出现,术后早期复发的发生率增加。此外,VEGF 过表达不仅预测术后早期复发,还预测无病生存率(P<0.001)和总生存率(P=0.002)。
本研究表明,VEGF 过表达是 I-III 期 CRC 患者术后早期复发的重要预测因子,可能有助于识别需要强化随访和治疗方案的患者。